Axa’s Perspecta Inc. Common Stock PRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-367,994
Closed -$8.86M 1382
2020
Q4
$8.86M Hold
367,994
0.03% 553
2020
Q3
$7.16M Buy
367,994
+11,100
+3% +$234K 0.03% 541
2020
Q2
$8.29M Buy
356,894
+98,800
+38% +$2.15M 0.03% 479
2020
Q1
$4.71M Buy
258,094
+201,445
+356% +$4.85M 0.02% 535
2019
Q4
$1.5M Sell
56,649
-288,282
-84% -$7.68M 0.01% 838
2019
Q3
$9.01M Buy
344,931
+304,054
+744% +$7.44M 0.04% 506
2019
Q2
$957K Sell
40,877
-401,104
-91% -$9.01M ﹤0.01% 984
2019
Q1
$8.94M Sell
441,981
-74,400
-14% -$1.5M 0.03% 482
2018
Q4
$8.89M Buy
516,381
+77,900
+18% +$1.73M 0.04% 450
2018
Q3
$11.3M Buy
+438,481
New +$10.2M 0.04% 440

Other funds holding PRSP

Axa's PRSP Position: Q1 2021 in Review

Axa sold out of Perspecta Inc. Common Stock (PRSP) in Q1 2021, closing a stake of 367,994 shares — an estimated $8.86M sold.

Axa first reported a position in PRSP in Q3 2018 and held it in 10 quarters. The position peaked at $11.3M in Q3 2018. 402 funds tracked by Wall St. Rank hold PRSP as of Q1 2021.

  • Axa reported no remaining Perspecta Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Axa sold 367,994 Perspecta Inc. Common Stock shares in Q1 2021, an estimated $8.86M.
  • Axa first reported a position in Perspecta Inc. Common Stock in Q3 2018 and held it in 10 quarters.
  • Axa's Perspecta Inc. Common Stock position peaked at $11.3M in Q3 2018.
  • 402 funds tracked by Wall St. Rank held Perspecta Inc. Common Stock as of Q1 2021.

Based on Axa's 13F filing for Q1 2021, filed 14 May 2021.